Anthropic has purchased stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The information And Eric Newcomer. Sources close to the deal confirmed to TechCrunch that the deal had been completed, but declined to comment on the amount.
This agreement comes as Anthropic continues its advancement in the healthcare and life sciences space, following its October announcement of Claude for Life Sciencesa tool that aims to help scientific researchers make discoveries.
Coefficient Bio founders Samuel Stanton and Nathan C. Frey launched the startup eight months ago, after both working in computational drug discovery at Genentech’s Prescient Design. Coefficient Bio used AI to make drug discovery and other forms of biological research more efficient.
The team, made up of around ten people, should join Anthropic’s health and life sciences team.
